Burning Rock and Abbisko Therapeutics Announce Strategic Partnership on Co-development of Companion Diagnostics for ABSK091
April 29, 2021 07:30 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 29, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced a strategic partnership with Abbisko Therapeutics...
Burning Rock Schedules First Quarter of 2021 Earnings Release on May 25, 2021
April 28, 2021 22:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 28, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock’s Liquid Biopsy Assay Achieved Strong Performance in the FDA-led SEQC2 Study, with Results Published on Nature Biotechnology
April 13, 2021 03:39 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, April 13, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that its liquid biopsy assay has achieved strong...
Burning Rock Reports Fourth Quarter and Full Year 2020 Financial Results
March 10, 2021 19:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, March 10, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces Preliminary Fourth Quarter and Full Year 2020 Results and Schedules Earnings Release on March 11, 2021
February 08, 2021 20:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Feb. 08, 2021 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces an Exclusive in-Licensing of a Risk Stratification Test for Early Stage Lung-Cancer Patients from Oncocyte in China
December 15, 2020 01:33 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into an exclusive licensing agreement...
Burning Rock Announces Pricing of Upsized Registered Secondary Public Offering of American Depositary Shares
December 04, 2020 06:34 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 04, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces Proposed Registered Secondary Public Offering of American Depositary Shares
December 01, 2020 18:47 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Reports Third Quarter 2020 Financial Results
November 20, 2020 06:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 20, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing...
Burning Rock Announces In-Licensing of Myriad myChoice® Tumor Testing in China
November 15, 2020 20:00 ET
|
Burning Rock Biotech Limited
GUANGZHOU, China, Nov. 15, 2020 (GLOBE NEWSWIRE) -- Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”) today announced that it entered into a development and...